Last 47 quarters of trend data · Healthcare · Cannabis
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.12 | — | — | 33.18 | — | 1.86 | — | 1.83 | — | 8.88 | — | — | — | — | 0.13 | — | — | — | — | — | — |
| — | — | — | +1711.0% | — | -79.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.58 | 0.64 | 1.23 | 0.64 | 0.92 | 0.67 | 0.68 | 0.67 | 1.02 | 0.72 | 0.84 | 0.88 | 0.89 | 0.63 | 0.84 | 1.28 | 1.86 | 1.64 | 4.26 | 4.42 | 5.70 |
| — | -5.0% | +82.4% | -4.4% | -9.9% | -6.4% | -19.7% | -23.4% | +14.7% | +13.2% | -0.2% | -31.3% | -52.1% | -61.3% | -80.2% | -71.2% | -67.4% | -80.0% | -48.0% | -14.2% | +182.2% | |
| P/B Ratio | 0.83 | 0.33 | 0.37 | 0.43 | 0.59 | 0.40 | 0.40 | 0.39 | 0.57 | 0.40 | 0.38 | 0.40 | 0.41 | 0.37 | 0.46 | 0.53 | 0.62 | 0.50 | 1.69 | 2.07 | 2.32 |
| — | -18.3% | -9.5% | +10.0% | +3.0% | +0.7% | +7.4% | -4.2% | +38.6% | +6.5% | -18.4% | -24.2% | -34.0% | -24.9% | -72.7% | -74.3% | -73.2% | -43.5% | +104.0% | +227.1% | +812.9% | |
| P/FCF | — | — | — | 5.49 | — | 11.64 | — | 2.47 | — | 18.54 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | +122.2% | — | -37.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | 6.40 | — | 0.92 | — | 0.93 | 23.14 | 6.01 | 3.80 | — | — | — | — | — | — | — | — | — | — |
| — | — | — | +585.7% | — | -84.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | 1.20 | 32.80 | — | 1.11 | — | 1.16 | 25.61 | 4.21 | — | — | 8.52 | — | 0.09 | — | — | — | — | — | 98.05 |
| — | — | — | +2727.7% | — | -73.5% | — | — | +200.6% | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.6% | -5.9% | 47.8% | 49.5% | 35.7% | 89.6% | 24.2% | 89.6% | 52.0% | 53.4% | 75.9% | 38.8% | 54.5% | 34.8% | 27.2% | -26.2% | -3.5% | 8.7% | -28.1% | 9.2% | 42.3% |
| — | -106.6% | +97.7% | -44.7% | -31.3% | +67.8% | -68.1% | +130.8% | -4.6% | +53.3% | +178.8% | +248.0% | +1672.0% | +298.3% | +196.8% | -384.7% | -108.2% | -76.1% | +80.9% | -49.0% | -18.3% | |
| Operating Margin | -14.6% | -70.2% | -66.1% | 5.1% | -20.2% | 41.8% | -33.6% | 41.8% | -2.9% | 1.1% | 4.7% | -27.3% | -17.2% | -19.3% | -29.3% | -116.1% | -109.3% | -127.3% | -143.5% | -92.1% | -65.5% |
| — | -268.0% | -96.8% | -87.8% | -585.8% | +3875.6% | -818.4% | +252.9% | +82.8% | +105.4% | +116.0% | +76.5% | +84.3% | +84.8% | +79.6% | -26.1% | -66.8% | -37.6% | +43.0% | -19.5% | -31.9% | |
| Net Margin | -38.0% | -6.0% | -149.7% | 1.9% | -57.0% | 35.9% | -27.1% | 35.9% | -14.8% | 7.8% | -25.8% | -26.5% | -0.8% | -36.0% | 661.9% | -106.0% | -104.8% | -1231.5% | -2006.9% | -123.4% | -19.8% |
| — | -116.6% | -451.8% | -94.6% | -283.8% | +359.5% | -5.0% | +235.7% | -1691.3% | +121.7% | -103.9% | +75.0% | +99.2% | +97.1% | +133.0% | +14.1% | -429.8% | -424.9% | -589.2% | +72.0% | +86.8% |
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -21.8% | -0.8% | -10.6% | 0.3% | -8.9% | 5.3% | -4.0% | 5.3% | -2.0% | 1.1% | -3.0% | -3.1% | -0.1% | -5.2% | 84.9% | -11.1% | -8.2% | -105.7% | -197.5% | -13.5% | -0.9% |
| — | -114.7% | -161.5% | -94.0% | -336.8% | +389.0% | -34.6% | +272.1% | -1950.4% | +120.7% | -103.5% | +72.2% | +98.8% | +95.1% | +143.0% | +17.9% | -811.0% | -1637.9% | -2592.8% | +1.4% | +81.0% | |
| ROA | -16.8% | -0.7% | -8.3% | 0.2% | -6.4% | 3.7% | -2.9% | 3.8% | -1.5% | 0.8% | -2.1% | -2.1% | -0.1% | -3.1% | 48.6% | -6.0% | -4.5% | -63.2% | -115.1% | -7.7% | -0.6% |
| — | -117.6% | -188.9% | -93.7% | -340.0% | +382.4% | -36.5% | +281.4% | -2204.6% | +125.4% | -104.3% | +65.3% | +98.6% | +95.2% | +142.2% | +21.9% | -610.5% | -1270.8% | -1932.5% | +27.8% | +82.2% | |
| ROIC | -7.4% | -8.3% | -3.6% | 0.6% | -2.5% | 5.4% | -4.3% | 5.2% | -0.3% | 0.1% | 0.5% | -2.8% | -1.8% | -2.4% | -3.3% | -11.0% | -8.7% | -10.8% | -12.3% | -8.9% | -2.4% |
| — | -255.2% | +15.5% | -88.3% | -646.2% | +4177.1% | -998.6% | +284.7% | +80.7% | +105.1% | +114.4% | +74.3% | +79.7% | +77.6% | +72.9% | -22.7% | -265.5% | -491.9% | -159.1% | -446.0% | -135.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.04 | 0.05 | 0.18 | 0.18 | 0.17 | 0.17 | 0.16 | 0.17 | 0.17 | 0.17 | 0.19 | 0.23 | 0.31 | 0.44 | 0.38 | 0.55 | 0.41 | 0.31 | 0.44 | 0.38 |
| — | -75.1% | -72.9% | +7.9% | +2.2% | +1.8% | -1.3% | -10.9% | -25.1% | -44.9% | -60.1% | -51.3% | -57.8% | -24.3% | +41.6% | -13.6% | +44.1% | +107.5% | +39.4% | +95.9% | +61.4% | |
| Debt / EBITDA | — | — | — | 9.02 | — | 2.49 | — | 2.39 | 33.25 | 15.42 | 10.45 | — | — | — | — | — | — | — | — | — | — |
| — | — | — | +277.9% | — | -83.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 5.94 | 5.36 | 5.94 | 3.06 | 3.41 | 2.97 | 4.31 | 3.30 | 3.83 | 3.76 | 3.42 | 3.79 | 3.29 | 2.32 | 2.02 | 4.08 | 4.07 | 5.13 | 2.32 | 1.98 | 4.08 |
| — | +80.7% | +37.6% | -7.4% | -10.8% | -21.2% | +26.0% | -12.9% | +16.4% | +62.0% | +69.6% | -7.2% | -19.1% | -54.8% | -13.0% | +106.0% | -0.3% | -10.3% | -60.5% | -60.0% | +117.2% | |
| Quick Ratio | 3.32 | 2.80 | 3.32 | 1.48 | 1.63 | 1.51 | 2.16 | 1.60 | 1.88 | 2.03 | 1.93 | 2.45 | 2.11 | 1.60 | 1.48 | 3.16 | 3.19 | 4.17 | 1.60 | 1.45 | 3.16 |
| — | +85.6% | +54.0% | -8.0% | -13.6% | -25.7% | +11.9% | -34.4% | -10.7% | +27.4% | +30.5% | -22.6% | -34.0% | -61.7% | -7.4% | +117.9% | +1.2% | -8.2% | -67.7% | -59.9% | +194.4% | |
| Interest Coverage | -30.25 | -102.23 | — | 1.04 | -20.14 | 19.16 | -6.67 | 17.51 | 1.28 | 5.44 | -5.83 | -5.85 | 1.14 | -2.86 | 136.48 | -5.56 | -5.04 | -40.98 | -38.24 | -3.75 | 0.21 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ACB stock.
Aurora Cannabis Inc.'s current P/E is -4.1x. The average P/E over the last 1 quarters is 33.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Aurora Cannabis Inc.'s current operating margin is -14.6%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Aurora Cannabis Inc.'s business trajectory between earnings reports.